A systematic review and meta-analysis was recently conducted to assess the diagnostic value of brain natriuretic peptide for CIN[13]; however, the meta-analysis focused only on patients with acute coronary syndrome patients, which refers to a small proportion of patients undergoing interventional therapy. This evidence concerns the gene NPPB and acute coronary syndrome.